当前位置:首页 - 行情中心 - 华兰疫苗(301207) - 财务分析

华兰疫苗

(301207)

  

流通市值:103.79亿  总市值:103.86亿
流通股本:6.01亿   总股本:6.01亿

华兰疫苗(301207)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.21亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益591853.40万元,未分配利润219408.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产691239.57万元,负债99386.17万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入59,961,774.2724,282,534.721,127,812,323.85957,363,018.62
营业总成本163,447,081.2349,573,022.32961,283,918.27757,727,172.19
其他经营收益
营业利润12,130,347.3936,468,293.21214,856,027.17305,871,419.4
利润总额11,201,943.9435,337,733.22214,545,726.25305,901,098.16
净利润20,797,156.832,777,072.14205,515,315.75267,359,727.86
每股收益
其他综合收益----
综合收益总额20,797,156.832,777,072.14205,515,315.75267,359,727.86
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计4,469,705,467.845,058,482,095.794,976,519,526.94,631,880,229.62
非流动资产:
非流动资产合计2,442,690,269.552,384,676,612.062,546,736,316.683,009,768,553.08
资产总计6,912,395,737.397,443,158,707.857,523,255,843.587,641,648,782.7
流动负债:
流动负债合计949,798,339.251,352,185,166.851,464,122,765.11,503,316,976.56
非流动负债:
非流动负债合计44,063,360.7443,255,764.3145,988,556.5844,150,617.79
负债合计993,861,699.991,395,440,931.161,510,111,321.681,547,467,594.35
所有者权益(或股东权益):
归属于母公司股东权益合计5,918,534,037.46,047,717,776.696,013,144,521.96,094,181,188.35
股东权益合计5,918,534,037.46,047,717,776.696,013,144,521.96,094,181,188.35
负债和股东权益合计6,912,395,737.397,443,158,707.857,523,255,843.587,641,648,782.7
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计557,752,953.21224,237,741.751,832,965,932.341,314,347,439.35
经营活动现金流出小计451,974,780.09226,825,367.561,364,924,489.86963,702,883.75
经营活动产生的现金流量净额105,778,173.12-2,587,625.81468,041,442.48350,644,555.6
投资活动产生的现金流量:
投资活动现金流入小计5,201,373,034.063,485,674,379.619,428,608,927.2714,744,165,919.04
投资活动现金流出小计4,988,858,844.993,585,330,704.9819,489,688,786.1914,777,971,609.27
投资活动产生的现金流量净额212,514,189.07-99,656,325.38-61,079,858.92-33,805,690.23
筹资活动产生的现金流量:
筹资活动现金流入小计--16,281,00016,281,000
筹资活动现金流出小计359,093,339.9530,660,000.01441,103,352.53442,826,685.86
筹资活动产生的现金流量净额-359,093,339.95-30,660,000.01-424,822,352.53-426,545,685.86
汇率变动对现金及现金等价物的影响170,007.4255,928.01-84,323.07-22,088.97
现金及现金等价物净增加额-40,630,970.34-132,848,023.19-17,945,092.04-109,728,909.46
期末现金及现金等价物余额582,404,049.57490,186,996.72623,035,019.91531,251,202.49
补充资料:
现金及现金等价物的净增加额-40,630,970.34--17,945,092.04-
TOP↑